Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. The journal ...
Cell Biology 2014 Q1 Cell Biology 2015 Q1 Cell Biology 2016 Q1 Cell Biology 2017 Q1 Cell Biology 2018 Q1 Cell Biology 2019 Q1 Cell Biology 2020 Q1 Cell Biology 2021 Q1 Cell Biology 2022 Q1 Cell Biology 2023 Q1 Oncology 2003 Q1 Oncology 2004 Q1 Oncology 2005 Q1 Oncology 2006 Q1 Oncology 20...
Cancer Cell International Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1475-2867.
Growth Factor Receptors Several proto-oncogene–derived proteins form a part of cell surface receptors for GFs. The binding of GF ligand to receptor is the initial stage of the delivery of mitogenic signals to cells. Their role in carcinogenesis may be through structural alterations in these protei...
YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.5253122978 202211.2-141481 202113.312-161957 202012.701453159236 20199.727536135753 20188.378555130932 20179.130632139291 20169.122648139655 20158.556506139464 20149.329679142659 20139.284670142970 20128.650625143522 ...
World Cancer Day 2021 The Editors of Cancer & Metabolism are delighted to highlight the following paper to mark the World Cancer Day: Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition...
(Narmani & Jafari, 2021). One example of a successful application of nanoparticle-based drug delivery is the use ofdocetaxel, a powerfulanticancer drugused in the treatment ofprostate cancer, breast cancer, non-small cell lung cancer, andgastric adenocarcinoma(Montero et al., 2005). A study ...
[109]). The impact of Arp2/3-WASP in cancer cell-cell fusion is unclear, but previous work suggested a substantial role of F-actin polymerization and associated cytoskeletal protein alignment to enable a permissive microenvironment for the fusion of breast cancer cells with MSC within the tumour...
Cancer Cell 39, 1091–1098 (2021). Herishanu, Y. et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood 137, 3165–3173 (2021). Lim, S. H. et al. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma. Lancet ...
growth rate and invasiveness. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a "normal" cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied ...